electroCore Stock (NASDAQ:ECOR)
Previous Close
$6.95
52W Range
$4.46 - $19.49
50D Avg
$5.62
200D Avg
$10.23
Market Cap
$54.91M
Avg Vol (3M)
$129.92K
Beta
0.80
Div Yield
-
ECOR Company Profile
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.